http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4296240-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-0812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F3-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-20 |
filingDate | 1980-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1981-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5502a74353551def4684dc8d978fae09 |
publicationDate | 1981-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4296240-A |
titleOfInvention | Silacycloalkane amides |
abstract | Anti-atherosclerotic agents of the formula: <IMAGE> wherein R1 is (a) alkyl having from 1 to 22 carbon atoms; or (b) of the formula <IMAGE> in which m is 0, 1 or 2, and each of R' and R'' is, independently, hydrogen, halo or lower alkyl or alkoxy; R2 and R3 are joined to form with the silicon atom a heterocyclic ring having from 3 to 20 ring members; and R is an aralkyl-, phenyl- tryptophanyl- or benzocycloalkyl-type radical, eg 1-butyl-N-[(2-(4'-methyl-phenyl)-1-phenylethyl]-1-silacyclohexane propanamide, are obtained by reducing corresponding alpha , beta -unsaturated analogs. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5496853-A |
priorityDate | 1980-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 207.